Our Story

RespoKare is engineered and manufactured by Innonix Technologies — a global biomedical materials R&D company with numerous intellectual properties and patents. Founded in 2007, it is a global leader in personal protective equipment (PPE), infection control and respiratory protection technologies.

The company’s current portfolio of active-protection-enabled face masks provides both consumers and clinicians with the infection control and respiration protection they require to combat airborne hazards, without compromising user comfort and aesthetics. 

First launched in Northern America before being available worldwide, RespoKare is a market leader in face masks with active protection to combat airborne viruses, bacteria, fungi, pollutants, toxic gases and allergens. At the heart of this groundbreaking new mask: A patented technology that eliminates 99.9 per cent of Covid-19 and 15 flu viruses. 

The patented, active-protection technology is the first of its kind on the market, and has received not only approval, but a distinguished classification by the FDA. The new classification, OUK, is applicable only to “Surgical Masks With Antimicrobial/antiviral Agent” to distinguish this innovation in anti-viral technology from underperforming competitors on the market. 

To date, millions of RespoKare antiviral surgical grade flat masks have been sold in the US since 2013, in collaboration with one of the country’s largest medical suppliers. It is now proudly supported by an extensive idsMED sales and distribution network in Indonesia, Singapore, Malaysia, Thailand, Vietnam, Philippines, Hong Kong, Taiwan, China — to offer unparalleled protection to those living in Asia and beyond.